In the study, released in a meeting of neurologists in Spain, 236 patients were given Cymbalta. In the first week of use, 31 percent of patients reported a 50 percent reduction in pain.
Eli Lilly has filed an application with the FDA to allow the drug to be prescribed for managing chronic pain.
- Get more L.A. breaking news, weather, traffic and sports
- Have a news tip? Send your tips, video, or pictures